News

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Based on the average brokerage recommendation (ABR), Ouster (OUST) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

TWLO's AI customer wins, including a seven-figure Car Finance 247 deal, add a growth driver as 2026 organic revenue guidance is raised.

Every time the overpriced chorus grows louder on Nvidia, one investor adds more shares, and the reasoning behind that move cuts against almost everything the skeptics keep quoting.

Why Deere stock is back in focus after its earnings surprise Deere (DE) moved back onto investor watchlists after a Q2 surprise, with US$12.61b in revenue and earnings topping analyst estimates, and the share price climbing 16.5% since that report. Over the past year Deere has moved from a steady compounder to a momentum story, with a year to date share price return of 46.54% and a 1 year total shareholder return of 47.77%. This points to investors reassessing both its growth potential and...

CRM's Slackbot users increase more than 150% sequentially as AI adoption and stronger Slack bookings support customer spending growth.

Wasatch Global Investors, an asset management company, released its “Long/Short Alpha Fund” Q2 2026 investor letter. The letter can be downloaded here. Small- and mid-cap growth stocks posted significant gains in Q2, led primarily by AI-related companies. The Russell 2500 Index rose 20.26%, while the Wasatch Long/Short Alpha Fund—Investor Class increased by 8.29%. However, the fund […]

AMD just handed OpenAI, Meta, and Anthropic gigawatt-scale reasons to abandon NVIDIA, and Lisa Su is making a bold promise about 2027 that Wall Street has not fully priced in yet.

SoFi Technologies (SOFI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks.com users have recently been watching GE Vernova (GEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Merck is beating the market year-to-date after a jump on positive Phase 3 data, while paying an annualized dividend of about $3.40 for a yield above 2.3%.

SK Hynix stock jumped following a report that the memory maker is exploring a deal with Intel.

Nokia stock is surging while rivals Ericsson and NVIDIA barely budge, and the reason comes down to a single announcement that reframes who actually wins when AI moves into mobile networks.

PBF Energy (PBF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.

NuScale's recent breakthrough moved its small modular reactor one step closer to commercial deployment.

JPMorgan trades at a cheaper valuation, but Nu's 43% revenue growth and positive free cash flow tell a starkly different profitability story.

A Reuters report about SK Hynix possibly producing memory chips on Intel's Ohio campus sent shares of both companies surging, but the real story is what the deal's structure could mean for Micron and the future of U.S. chip manufacturing.

Uber Technologies (NYSE:UBER) and Costco Wholesale (NASDAQ:COST) have expanded their US delivery partnership to 47 states, up from 17, making nearly 600 Costco locations available through the Uber Eats platform. The companies said the expanded service allows Costco members to place orders for on-demand or scheduled delivery through the Uber Eats app.

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]

SPCX's $8.05 billion in announced defense awards, Starshield contracts and Golden Dome role put its expanding military-space business in focus.

Rocket Lab (RKLB) stock has traded between $39.48 and $150.23 over the past 52 weeks. It now sits about 58% below its 52-week high, and anyone who bought twelve months ago is still up about 19%. None of that tells you what you would be buying today. Rocket Lab sells two quite different things, and the one its name points at is the smaller of them.

Alluvium Asset Management, an asset management company, released its “Conventum – Alluvium Global Fund” second-quarter 2026 investor letter. The letter can be downloaded here. The second quarter reflected a sharp shift from geopolitical uncertainty and oil market volatility to a powerful equity rally led by semiconductor companies. Despite the broader market strength, the Fund declined […]

Investing.com -- In a note to clients on Wednesday, Melius Research made the case that Intel shares could roughly double from current levels, arguing the chipmaker's foundry business is becoming increasingly valuable amid an AI-driven scramble for domestic chip production.

If all goes to plan, SpaceX will test its huge fully-reusable rocket, Starship, again on Sept. 22. It will be the 14th test for Starship. It will be the first time the upper stage enters a stable Earth orbit, completing six orbits on a 10-hour mission.

Chasing the biggest dividend yields can quietly sabotage long-term income, and three mega-cap businesses with some of the smallest payouts on the market reveal exactly why the math works against most income investors.

This beaten-down growth stock could still produce incredible earnings growth at an attractive valuation.

West Pharmaceutical Services has outperformed the Nasdaq over the past year, and analysts are highly optimistic about the stock’s prospects.

One builds the machines; the other builds the chips. Their vastly different margins and valuations reveal which supply-chain player offers better returns.